Estradiol modulates uterine 18 kDa translocator protein gene expression in uterus and kidney of rats

Molecular and Cellular Endocrinology

Volumn 307, Issue 1-2, 2009, Pages 43-49

  Mazurika, Caroline ^a   Veenman, Leo ^a   Weizman, Ronit ^b   Bidder, Miri ^a   Leschiner, Svetlana ^a   Golani, Idit ^a   Spanier, Ilana ^a   Weisinger, Gary ^c   Gavish, Moshe ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

18 kDa translocator protein; Estradiol; Gene expression; Kidney; PBR; Peripheral type benzodiazepine receptor; TSPO; Uterus

Indexed keywords

BENZODIAZEPINE RECEPTOR; ESTRADIOL; RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; IN VIVO STUDY; KIDNEY PARENCHYMA; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION; STEADY STATE; UTERUS;

ANIMALS; CARRIER PROTEINS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; KIDNEY; MOLECULAR WEIGHT; OVARIECTOMY; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UTERUS;

EID: 67349183698     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.04.001     Document Type: Article

References (88)

1. Alagwu E.A., and Nneli R.O. Effect of ovariectomy on the level of plasma sex hormones in albino rats. Niger J. Physiol. Sci. 20 (2005) 90-94
2. Amiri Z., Weizman R., Katz Y., Burstein O., Edoute Y., Lochner A., and Gavish M. Testosterone and cyproterone acetate modulate peripheral but not central benzodiazepine receptors in rats. Brain Res. 553 (1991) 155-158
3. Anholt R.R., De Souza E.B., Oster-Granite M.L., and Snyder S.H. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 233 (1985) 517-526
4. Avital A., Richter-Levin G., Leschiner S., Spanier I., Veenman L., Weizman A., and Gavish M. Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney. Neuropsychopharmacology 25 (2001) 669-678
5. 3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem. 49 (1987) 1407-1414
6. Bar-Ami S., Fares F., and Gavish M. Effect of hypophysectomy and hormone treatment on the induction of peripheral-type benzodiazepine binding sites in female rat genital axis. Horm. Metab. Res. 21 (1989) 106-107
7. Bar-Ami S., Amiri Z., Fares F., and Gavish M. Modulation of peripheral benzodiazepine receptors in female rat genital organs by various gonadal steroids. Life Sci. 54 (1994) 1965-1975
8. Bar-Ami S., Bendel N., Leschiner S., Levin E., Veenman L., and Gavish M. The effects of prostaglandin F2alpha treatment on peripheral-type benzodiazepine receptors in the ovary and uterus during pseudopregnancy of rats. Biochem. Pharmacol. 71 (2006) 472-478
9. Bessler H., Weizman R., Gavish M., Notti I., and Djaldetti M. Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J. Neuroimmunol. 38 (1992) 19-25
10. Bessler H., Caspi B., Gavish M., Rehavi M., and Weizman A. Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands. Clin. Neuropharmacol. 20 (1997) 215-223
11. Bitran D., Carlson D., Leschiner S., and Gavish M. Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density. Eur. J. Pharmacol. 361 (1998) 235-242
12. Bohen S.P., Kralli A., and Yamamoto K.R. Hold'em and fold'em: chaperones and signal transduction. Science 268 (1991) 1303-1304
13. Bono F., Lamarche I., Prabonnaud V., Le Fur G., and Herbert J.M. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem. Biophys. Res. Commun. 265 (1999) 457-461
14. Bribes E., Casellas P., Vidal H., Dussossoy D., and Casellas D. Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin II-induced hypertension. J. Am. Soc. Nephrol. 13 (2002) 1-9
15. Bryant D.N., Sheldahl L.C., Marriott L.K., Shapiro R.A., and Dorsa D.M. Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine 29 (2006) 199-207
16. Carmel I., Fares F.A., Leschiner S., Scherubl H., Weisinger G., and Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem. Pharmacol. 58 (1999) 273-278
17. Chappell M.C., Westwood B.M., and Yamaleyeva L.M. Differential effects of sex steroids in young and aged female mRen2. Lewis rats: a model of estrogen and salt-sensitive hypertension. Gend. Med. 5 Suppl. A (2008) S65-S75
18. Chelli B., Falleni A., Salvetti F., Gremigni V., Lucacchini A., and Martini C. Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem. Pharmacol. 61 (2001) 695-705
19. Chelli B., Lena A., Vanacore R., Pozzo E.D., Costa B., Rossi L., Salvetti A., Scatena F., Ceruti S., Abbracchio M.P., Gremigni V., and Martini C. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem. Pharmacol. 68 (2004) 125-134
20. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-199
21. Daftary G.S., and Taylor H.S. Endocrine regulation of HOX genes. Endocr. Rev. 27 (2006) 331-355
22. Delavoie F., Li H., Hardwick M., Robert J.C., Giatzakis C., Péranzi G., Yao Z.X., Maccario J., Lacapère J.J., and Papadopoulos V. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42 (2003) 4506-4519
23. Epplein M., Reed S.D., Voigt L.F., Newton K.M., Holt V.L., and Weiss N.S. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am. J. Epidemiol. 168 (2008) 563-570 discussion 571-6
24. Fares F., Bar-Ami S., Brandes J.M., and Gavish M. Gonadotropin- and estrogen-induced increase of peripheral-type benzodiazepine binding sites in the hypophyseal-genital axis of rats. Eur. J. Pharmacol. 133 (1987) 97-102
25. Fares F., Bar-Ami S., Haj-Yehia Y., and Gavish M. Hormonal regulation of peripheral benzodiazepine binding sites in female rat adrenal gland and kidney. J. Recept. Res. 9 (1989) 143-157
26. Faure J.P., Hauet T., Han Z., Goujon J.M., Petit I., Mauco G., Eugene M., Carretier M., and Papadopoulos V. Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury. J. Pharmacol. Exp. Ther. 302 (2002) 861-870
27. Galiegue S., Tinel N., and Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr. Med. Chem. 10 (2003) 1563-1572
28. Garnier M., Dimchev A.B., Boujrad N., Price J.M., Musto N.A., and Papadopoulos V. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol. Pharmacol. 45 (1994) 201-211
29. Gavish M., Okun F., Weizman A., and Youdim M.B. Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur. J. Pharmacol. 127 (1986) 147-151
30. Gavish M., Weizman A., Youdim M.B., and Okun F. Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats. Brain Res. 409 (1987) 386-390
31. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., and Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51 (1999) 629-650
32. Gehlert D.R., Yamamura H.I., and Wamsley J.K. Autoradiographic localization of "peripheral-type" benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch. Pharmacol. 328 (1985) 454-460
33. Giatzakis C., and Papadopoulos V. Differential utilization of the promoter of peripheral-type benzodiazepine receptor by steroidogenic versus nonsteroidogenic cell lines and the role of Sp1 and Sp3 in the regulation of basal activity. Endocrinology 145 (2004) 1113-1123
34. Giatzakis C., Batarseh A., Dettin L., and Papadopoulos V. The role of Ets transcription factors in the basal transcription of the translocator protein (18 kDa). Biochemistry 46 (2007) 4763-4774
35. Golani I., Weizman A., Leschiner S., Spanier I., Eckstein N., Limor R., Yanai J., Maaser K., Scherübl H., Weisinger G., and Gavish M. Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry 40 (2001) 10213-10222
36. Härkönen P.L., Mäkelä S.I., Valve E.M., Karhukorpi E.K., and Väänänen H.K. Differential regulation of carbonic anhydrase II by androgen and estrogen in dorsal and lateral prostate of the rat. Endocrinology 128 (1991) 3219-3227
37. Hauet T., Han Z., Wang Y., Hameury F., Jayle C., Gibelin H., Goujon J.M., Eugene M., and Papadopoulos V. Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model. Transplantation 74 (2002) 1507-1515
38. Hirsch J.D., Beyer C.F., Malkowitz L., Beer B., and Blume A.J. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol. Pharmacol. 35 (1989) 157-163
39. Ikezaki K., Black K.L., Santori E.M., Smith M.L., Becker D.P., Payne B.A., and Toga A.W. Three-dimensional comparison of peripheral benzodiazepine binding and histological findings in rat brain tumor. Neurosurgery. 27 (1990) 78-82
40. Karp L., Weizman A., Tyano S., and Gavish M. Examination stress, platelet peripheral benzodiazepine binding sites, and plasma hormone levels. Life Sci. 44 (1989) 1077-1082
41. Kelly-Hershkovitz E., Weizman R., Spanier I., Leschiner S., Lahav M., Weisinger G., and Gavish M. Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J. Biol. Chem. 273 (1998) 5478-5483
42. Kletsas D., Li W., Han Z., and Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem. Pharmacol. 67 (2004) 1927-1932
43. Kugler W., Veenman L., Shandalov Y., Leschiner S., Spanier I., Lakomek M., and Gavish M. Ligands of the mitochondrial 18 kDa Translocator Protein attenuate apoptosis in human glioblastoma cells exposed to erucylphosphohomocholine. Cell. Oncol. 30 (2008) 435-450
44. Lacapère J.J., and Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68 (2003) 569-585
45. Landau M., Weizman A., Zoref-Shani E., Beery E., Wasseman L., Landau O., Gavish M., Brenner S., and Nordenberg J. Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochem. Pharmacol. 56 (1998) 1029-1034
46. Leducq N., Bono F., Sulpice T., Vin V., Janiak P., Le Fur G., O'Connor S.E., and Herbert J.M. Role of peripheral benzodiazepine receptors in mitochondrial, cellular and cardiac damage induced by oxidative stress and ischemia-reperfusion. J. Pharmacol. Exp. Ther. 306 (2003) 828-837
47. Levin E., Premkumar A., Veenman L., Kugler W., Leschiner S., Spanier I., Weisinger G., Lakomek M., Weizman A., Snyder S.H., Pasternak G.W., and Gavish M. The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell Line. Biochemistry 44 (2005) 9924-9935
48. Lin D., Chang Y.J., Strauss III J.F., and Miller W.L. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternatively splicing in normal tissues and in a patient with congenitall lipoid adrenal hyperplasia. Genomics 18 (1993) 643-650
49. Lux-Lantos V.A., Thyssen S.M., Chamson A., and Libertun C. Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: direct and indirect actions. Life Sci. 57 (1995) 291-300
50. Maruyama T., and Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr. J. 55 (2008) 795-810
51. McEnery M.W., Snowman A.M., Trifiletti R.R., and Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3170-3174
52. 3H]PK-11195 as a marker for gliosis. Acta Neurochir. 137 (1995) 207-216
53. 3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci. Lett. 133 (1991) 20-24
54. Nepveu A., Levine R.A., Campisi J., Greenberg M.E., Ziff E.B., and Marcu K.B. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells. Oncogene 1 (1987) 243-250
55. Nepveu A., and Marcu K.B. Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J. 5 (1986) 2859-2865
56. Neves-E-Castro M. Association of ovarian and uterine cancers with postmenopausal hormonal treatments. Clin. Obstet. Gynecol. 51 (2008) 607-617
57. Nolan L.A., and Levy A. The effects of testosterone and oestrogen on gonadectomised and intact male rat anterior pituitary mitotic and apoptotic activity. J. Endocrinol. 188 (2006) 387-396
58. Papadopoulos V., Mukhin A.G., Costa E., and Krueger K.E. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265 (1990) 3772-3779
59. Papadopoulos V., Guarneri P., Krueger K.E., Guidotti A., and Costa E. Pregnenolone biosynthesis in C6 glioma cell mitochondria: regulation by diazepam-binding inhibitor mitochondrial receptor. Proc. Natl. Acad. Sci. USA 89 (1992) 5118-5122
60. Papadopoulos V., Amri H., Boujrad N., Cascio C., Culty M., Garnier M., Hardwick M., Li H., Vidic B., Brown A.S., Reversa J.L., Bernassau J.M., and Drieu K. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62 (1997) 21-28
61. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapère J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., and Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine. receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27 (2006) 402-409
62. Parola A.L., Stump D.G., Peperel D.J., Krueger K.E., Regan J.W., and Laird H.E. Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. J. Biol. Chem. 266 (1991) 14082-14087
63. Piechaczyk M., Blanchard J.M., Marty L., Dani C., Panabieres F.E., Sabouty S., Fort P., and Jeantheur P. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 12 (1984) 56951-56963
64. Pubill D., Verdaguer E., Canudas A.M., Sureda F.X., Escubedo E., Camarasa J., Pallas M., and Camins A. Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br. J. Pharmacol. 132 (2001) 693-702
65. 6 glioma. Neurology. 38 (1988) 1255-1262
66. Riond J., Mattei M.G., Kaghad M., Dumont X., Guillemot J.C., Le Fur G., Caput D., and Ferraram P. Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur. J. Biochem. 195 (1991) 305-311
67. Ruff M.R., Pert C.B., Weber R.J., Wahl L.M., Wahl S.M., and Paul S.M. Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science 229 (1985) 1281-1283
68. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
69. Shoukrun R., Veenman L., Shandalov Y., Leschiner S., Spanier I., Karry R., Katz Y., Weisinger G., Weizman A., and Gavish M. The 18 kDa Translocator Protein, formerly known as the peripheral-type benzodiazepine receptor, confers pro-apoptotic and anti-neoplastic effects in a human colorectal cancer cell line. Pharmacogenet. Genom. 18 (2008) 977-988
70. Sprengel R., Werner P., Seebury P.H., Mukhin A.G., Santi M.R., Grayson D.R., Guidotti A., and Krueger K.E. Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J. Biol. Chem. 264 (1989) 20415-20421
71. Veenman L., and Gavish M. Peripheral-type benzodiazepine receptors: Their implication in brain Disease. Drug Dev. Res. 50 (2000) 355-370
72. Veenman L., and Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol. Ther. 110 (2006) 503-524
73. Veenman L., Leschiner S., Spanier I., Weisinger G., Weizman A., and Gavish M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) components in the rat brain. J. Neurochem. 80 (2002) 917-927
74. Veenman L., Levin E., Weisinger G., Leschiner S., Spanier I., Snyder S.H., Weizman A., and Gavish M. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem. Pharmacol. 68 (2004) 689-698
75. Veenman L., Papadopoulos V., and Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): Regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Design. 13 (2007) 2385-2405
76. Veenman L., Shandalov Y., and Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg Biomembr. 40 (2008) 199-205
77. Veiga S., Azcoitia I., and Garcia-Segura L.M. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res. 80 (2005) 129-137
78. Wang J.K.T., Morgan J.I., and Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. USA 81 (1984) 753-756
79. Weisinger G., Gavish M., Mazurika C., and Zinder O. Transcription of actin, cyclophilin and GAPDH genes: tissue- and treatment-specificity. Biochem. Biophys. Acta 1446 (1999) 225-232
80. Weisinger G., Zinder O., DeCristofaro J.D., and LaGamma E.F. Novel transcriptional mechanisms are involved in regulating preproenkephalin gene expression in vivo. Biochem. Biophys. Res. Commun. 246 (1998) 524-531
81. Weizman A., Amir Z., Katz Y., Snyder S.H., and Gavish M. Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal. Brain Res. 572 (1992) 72-75
82. Weizman R., Laor N., Karp L., Dagan E., Reiss A., Dar D.E., Wolmer L., and Gavish M. Alteration of platelet benzodiazepine receptors by stress of war. Am. J. Psychiatry. 151 (1994) 766-767
83. A receptor and central-type and peripheral-type benzodiazepine receptors. Brain Res. 752 (1997) 307-314
84. Weizman R., Leschiner S., Schlegel W., and Gavish M. Peripheral-type benzodiazepine receptor ligands and serum steroid hormones. Brain Res. 772 (1997) 203-208
85. White J.D., and LaGamma E.F. Neuropeptide gene transcription in central and peripheral nervous system tissue by nuclear run-on assay. Methods Enzymol. 168 (1989) 681-690
86. Wise P.M., and Ratner A. Effect of ovariectomy on plasma LH, FSH, estradiol, and progesterone and medial basal hypothalamic LHRH concentrations old and young rats. Neuroendocrinology 30 (1980) 15-19
87. Zisterer D.M., Gorman A.M., Williams D.C., and Murphy M.P. The effects of the peripheral-type benzodiazepine acceptor ligands, Ro 5-4864 and PK 11195, on mitochondrial respiration. Meth. Find. Exp. Clin. Pharmacol. 14 (1992) 85-90
88. Zhang K., Demeure O., Belliard A., Goujon J.M., Favreau F., Desurmont T., Mauco G., Barrière M., Carretier M., Milan D., Papadopoulos V., and Hauet T. Cloning, sequencing, and chromosomal localization of pig peripheral benzodiazepine receptor: three different forms produced by alternative splicing. Mamm. Genome 17 (2006) 1050-1962